8-K: Rayonier Advanced Materials Reports Strong Q2 2024 Results, Raises Full-Year Guidance

Rayonier Advanced Materials announced strong second-quarter results, driven by improved product mix and cost management, leading to increased full-year EBITDA and free cash flow guidance.

Summary

• Rayonier Advanced Materials (RYAM) reported net sales of $419 million for the second quarter of 2024, a $34 million increase compared to the same period last year.
• Income from continuing operations was $8 million, a significant improvement of $24 million year-over-year.
• Adjusted EBITDA from continuing operations reached $68 million, up $41 million from the prior year quarter, which included $10 million in Canada Emergency Wage Subsidy (CEWS) benefits.
• The company generated $69 million in Adjusted Free Cash Flow, supported by a $39 million sale of softwood lumber duty refund rights.
• RYAM's total debt stands at $778 million, with net secured debt at $659 million, resulting in a covenant net secured debt ratio of 3.4 times.
• The company has increased its 2024 Adjusted EBITDA guidance to a range of $205 million to $215 million and Adjusted Free Cash Flow guidance to $100 million to $110 million.
• RYAM is targeting a covenant net secured debt ratio of less than 3.0 times by the end of 2024.
• The bioethanol facility in Tartas, France, began shipments in April and is ramping up production.

Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to strong financial results, increased guidance, and progress in strategic initiatives. However, there are some concerns about the suspension of the Temiscaming plant and potential risks.

Positives

• The company saw a significant increase in net sales, income from continuing operations, and adjusted EBITDA compared to the same quarter last year.
• The company generated strong adjusted free cash flow, supported by the sale of duty refund rights.
• The company has increased its full-year guidance for both Adjusted EBITDA and Adjusted Free Cash Flow.
• The company is making progress on its biomaterials strategy, with the bioethanol facility in Tartas beginning shipments.
• The company is actively pursuing the refinancing of its 2026 Senior Notes before they become current in January 2025.
• The company is exploring the potential sale of its Paperboard and High-Yield Pulp assets at its Temiscaming site.

Negatives

• The company has suspended operations at its Temiscaming High Purity Cellulose plant, which will result in one-time operating charges of $25 million to $30 million in 2024.
• The company expects to incur non-cash charges in the third quarter of 2024 related to asset impairments due to the Temiscaming plant suspension.
• High-Yield Pulp sales decreased by $11 million, or 25 percent, compared to the same prior year quarter.
• Paperboard sales prices decreased by 8 percent and 10 percent during the quarter and six-month periods, respectively, due to mix and increased competitive activity from European imports.
• Corporate costs are expected to increase in the second half of 2024 due to the ERP transformation project and less favorable foreign exchange rates.

Risks

• The company's business is subject to macroeconomic and industry risks, including geopolitical conflicts, epidemics, and cyclical market conditions.
• The company faces competition and fluctuations in pricing and volume.
• Changes in the availability and price of raw materials and energy could adversely affect the company.
• The company is subject to risks associated with doing business outside of the United States, including foreign currency exchange fluctuations and trade restrictions.
• A material disruption at any of the company's manufacturing plants could impact sales and profitability.
• The company depends on third parties for transportation services, and unfavorable changes in costs could affect the business.
• The company may need to make significant additional cash contributions to its retirement benefit plans.
• The company has debt obligations that could affect its ability to meet its obligations.
• The company may require additional financing in the future, which may not be available on favorable terms.

Future Outlook

The company expects 2024 Adjusted EBITDA to be between $205 million and $215 million and Adjusted Free Cash Flow to be between $100 million and $110 million. The company is actively pursuing the refinancing of its 2026 Senior Notes before they become current in January 2025 and believes it will secure refinancing at satisfactory terms. The company also expects the suspension of the Temiscaming HPC plant to be positive to Adjusted EBITDA and increase free cash flow by $25 million to $30 million in 2024.

Management Comments

• De Lyle Bloomquist, President and CEO of RYAM, stated that the company delivered another solid quarter on its financial results as they continued to improve their product mix and manage operating costs.
• Mr. Bloomquist also noted that demand for cellulose specialties has remained higher than expectations and margins have improved.
• Mr. Bloomquist concluded that with the improvement in financial metrics, the company is confident that it will refinance its senior secured notes prior to them becoming current in early 2025.

Industry Context

The company's focus on cellulose specialties and biomaterials aligns with the growing demand for sustainable and renewable products. The suspension of the Temiscaming HPC plant reflects a strategic shift away from commodity viscose pulp, which is a common trend in the industry as companies seek higher-margin products. The company's bioethanol facility in Tartas is an example of the industry's move towards green energy and renewable products.

Comparison to Industry Standards

• Compared to competitors in the specialty cellulose market, RYAM's focus on higher-margin products and cost management appears to be yielding positive results, as evidenced by the increased EBITDA and free cash flow.
• The company's move to suspend operations at the Temiscaming HPC plant is a strategic decision to reduce exposure to commodity viscose pulp, which is a common strategy among companies seeking to improve profitability.
• The company's bioethanol facility in Tartas is a significant step in the biomaterials market, which is a growing trend in the industry.
• The company's debt leverage ratio of 3.4 times is within industry norms, and the target of less than 3.0 times by the end of 2024 is a positive sign of financial health.
• Companies like Domtar and International Paper, which also operate in the pulp and paper industry, have been focusing on similar strategies to improve profitability and reduce exposure to commodity markets.

Stakeholder Impact

• Shareholders will likely react positively to the strong financial results and increased guidance.
• Employees may be affected by the suspension of operations at the Temiscaming plant, including potential job losses.
• Customers may benefit from the company's focus on higher-value products and new biomaterials.
• Suppliers may be impacted by changes in production and sourcing.
• Creditors may view the company's improved financial performance and debt reduction efforts favorably.

Next Steps

• The company will continue to ramp up production at the bioethanol facility in Tartas.
• The company will continue to advance other Biomaterials projects, including bioethanol and prebiotics at its Fernandina and Jesup plants, respectively.
• The company will actively pursue the refinancing of its 2026 Senior Notes.
• The company will continue to explore the potential sale of its Paperboard and High-Yield Pulp assets at its Temiscaming site.
• The company will host a conference call on August 7, 2024, to discuss the results.

Key Dates

Keywords

cellulose specialties, EBITDA, free cash flow, biomaterials, bioethanol, high purity cellulose, paperboard, high-yield pulp, debt refinancing, Temiscaming